financetom
Business
financetom
/
Business
/
Viridian Therapeutics Q3 Net Loss Narrows, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viridian Therapeutics Q3 Net Loss Narrows, Revenue Rises
Nov 5, 2025 6:28 AM

09:13 AM EST, 11/05/2025 (MT Newswires) -- Viridian Therapeutics ( VRDN ) reported a Q3 net loss Wednesday of $0.34 per share, narrowing from a loss of $0.88 a year earlier.

Four analysts polled by FactSet expected a loss of $1.16.

Total revenue for the quarter ended Sept. 30 was $70.6 million, compared with $86,000 a year earlier.

Analysts' estimates weren't available for comparison.

Shares of the company were up 5.9% in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved